Krug, David http://orcid.org/0000-0001-8811-5416
Zaman, Adrian
Eidinger, Lina
Grehn, Melanie
Boda-Heggemann, Judit
Rudic, Boris
Mehrhof, Felix
Boldt, Leif-Hendrik
Hohmann, Stephan
Merten, Roland
Buergy, Daniel
Fleckenstein, Jens
Kluge, Anne
Rogge, Annette
Both, Marcus
Rades, Dirk
Tilz, Roland Richard
Olbrich, Denise
König, Inke R.
Siebert, Frank-Andre
Schweikard, Achim
Vonthein, Reinhard
Bonnemeier, Hendrik
Dunst, Jürgen
Blanck, Oliver
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Article History
Received: 9 February 2023
Accepted: 23 April 2023
First Online: 7 June 2023
Conflict of interest
: D. Buergy reports personal fees from Siemens AG, NB Capital Research GmbH, NB Capital ApS, b.e. Imaging GmbH, and PharmaMar, all outside the submitted work. D. Krug has received honoraria from MSD Sharp & Dohme and Pfizer as well as research funding from Merck KGaA, outside the submitted work. B. Rudic received travel grants and personal fees from Boston Scientific Medizintechnik GmbH, outside of the submitted work. J. Boda-Heggemann reports personal fees from EBAMed SA, outside the submitted work. S. Hohmann received travel grants from Boston Scientific Medizintechnik GmbH, outside of the submitted work. L.-H. Boldt received honoraria from Biotronik, Boston Scientific, and Pfizer, outside of the submitted work. O. Blanck is the section editor for medical physics of the <i>Strahlentherapie und Onkologie</i> journal. A. Zaman, L. Eidinger, M. Grehn, F. Mehrhof, R. Merten, J. Fleckenstein, A. Kluge, A. Rogge, M. Both, D. Rades, R. R. Tilz, D. Olbrich, I. R. König, F.-A. Siebert, A. Schweikard, R. Vonthein, H. Bonnemeier, and J. Dunst declare that they have no competing interests.
: The study was approved by the German Radiation Protection Agency (<i>Bundesamt für Strahlenschutz</i>, reference number Z5-22463/2-2018-054) and by the leading independent ethics committee at the Christian-Albrechts-University of Kiel (reference number 555/18) as well as by the respective independent ethics committees of the participating centers. All treated patients gave their written informed consent for participation in the study and hence for publication of their anonymized data.